What does BPC-157 research show?

BPC-157 ("Body Protection Compound — 157") is a synthetic 15-amino-acid sequence derived from a protein found in human gastric juice. It has been widely studied in preclinical (rodent) models for its effects on tissue repair, gut mucosal recovery, and angiogenesis (formation of new blood vessels).

Mechanism research suggests:

• Upregulation of growth factor pathways (e.g. VEGF) implicated in angiogenesis and wound healing.
• Modulation of the nitric oxide (NO) system, which is relevant to vascular and gut physiology.
• Influence on fibroblast and tendon-cell migration in tissue-repair models.

Research context:

• The published literature is overwhelmingly preclinical. Human trial data is limited.
• BPC-157 is sold strictly for in-vitro and preclinical laboratory investigation.
• It is not FDA approved for any human or veterinary use.

For our internal mechanism overview, see the BPC-157 product page and the broader Healing pathway.